Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pathology, Research and Practice
|
October 12, 2016
Evaluation of general and coronary atherosclerosis and malignant disease demonstrates inverse correlations for specific cancer types as well as cancer in general
Anne Jirasek, Juliana Knief, Mario Deng, et al.
Pathology, Research and Practice
|
December 4, 2016
ERG expression in multiple myeloma-A potential diagnostic pitfall
Juliana Knief, Katharina Reddemann, Jan Gliemroth, et al.
Anticancer Research
|
November 1, 2016
High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction
Juliana Knief, Katharina Reddemann, Ekaterina Petrova, et al.
Histology and Histopathology
|
November 18, 2016
Expression of cyclooxygenase-2 has no impact on survival in adenocarcinoma of the esophagogastric junction but is associated with favourable clinicopathologic features
Juliana Knief, Katharina Reddemann, Ekaterina Petrova, et al.
Haematologica
|
May 19, 2018
t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform
Ingram Iaccarino, Lamis Afify, Sietse M Aukema, et al.
Journal of Clinical Pathology
|
December 25, 2016
Prognostic implications of <i>RASAL1</i> expression in oesophagogastric adenocarcinoma
Juliana Knief, Katharina Reddemann, Pamela Lazar-Karsten, et al.
Haematologica
|
August 5, 2018
Programmed cell death protein-1 (PD-1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse during anti-PD-1-treatment
Stephanie Sasse, Katharina Reddemann, Arjan Diepstra, et al.
Haematologica
|
January 2, 2019
Programmed cell death protein1 (PD1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse after conventional chemotherapy and at relapse on anti-PD1 treatment
Stephanie Sasse, Katharina Reddemann, Arjan Diepstra, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 26, 2014
Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases
Juliana Knief, Niklas Gebauer, Veronica Bernard, et al.
Anticancer Research
|
April 12, 2015
Dysregulation of microRNAs in angioimmunoblastic T-cell lymphoma
Katharina Reddemann, Damian Gola, Arne Schillert, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pathology, Research and Practice
|
October 12, 2016
Evaluation of general and coronary atherosclerosis and malignant disease demonstrates inverse correlations for specific cancer types as well as cancer in general
Anne Jirasek, Juliana Knief, Mario Deng, et al.
Pathology, Research and Practice
|
December 4, 2016
ERG expression in multiple myeloma-A potential diagnostic pitfall
Juliana Knief, Katharina Reddemann, Jan Gliemroth, et al.
Anticancer Research
|
November 1, 2016
High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction
Juliana Knief, Katharina Reddemann, Ekaterina Petrova, et al.
Histology and Histopathology
|
November 18, 2016
Expression of cyclooxygenase-2 has no impact on survival in adenocarcinoma of the esophagogastric junction but is associated with favourable clinicopathologic features
Juliana Knief, Katharina Reddemann, Ekaterina Petrova, et al.
Haematologica
|
May 19, 2018
t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform
Ingram Iaccarino, Lamis Afify, Sietse M Aukema, et al.
Journal of Clinical Pathology
|
December 25, 2016
Prognostic implications of <i>RASAL1</i> expression in oesophagogastric adenocarcinoma
Juliana Knief, Katharina Reddemann, Pamela Lazar-Karsten, et al.
Haematologica
|
August 5, 2018
Programmed cell death protein-1 (PD-1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse during anti-PD-1-treatment
Stephanie Sasse, Katharina Reddemann, Arjan Diepstra, et al.
Haematologica
|
January 2, 2019
Programmed cell death protein1 (PD1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse after conventional chemotherapy and at relapse on anti-PD1 treatment
Stephanie Sasse, Katharina Reddemann, Arjan Diepstra, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 26, 2014
Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases
Juliana Knief, Niklas Gebauer, Veronica Bernard, et al.
Anticancer Research
|
April 12, 2015
Dysregulation of microRNAs in angioimmunoblastic T-cell lymphoma
Katharina Reddemann, Damian Gola, Arne Schillert, et al.
Page
of 1